Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

The global genome editing market was valued at USD 4.9 billion in 2021 and is projected to reach USD 18.6 billion by 2030, growing at a CAGR of 19.3% from 2022 to 2030. The increasing utilization of ...

The immediate reaction to the Colossal Biosciences’ claims from a broad section of the scientific community was highly ...

Research reveals previously unknown regulatory workings of genes that control T cells, with findings that benefit our understanding of immune regulation and autoimmunity, and could be used in the ...

Newco Brink Therapeutics SAS is poised to work on the next chapter in genome editing after raising €3.5 million (US$4 million) in seed funding to discover and develop programmable recombinase enzymes.

A US bio firm has announced the "rebirth" of an extinct carnivore called the dire wolf by using genome editing technology.

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

The Workshop on Genome Editing Tool Developments and Clinical Applications (#HKCRISPR25) was successfully held at the Hong ...

The Birbal Sahni Institute of Palaeosciences (BSIP) in the city, in collaboration with the Zoological Survey of India (ZSI), ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

Modern genome editing techniques, including CRISPR systems, hold great potential for treating genetic diseases. However, delivering these molecular tools reliably to their target cells remains a ...